Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'

Eur J Cancer. 2016 Mar:56:181-182. doi: 10.1016/j.ejca.2015.11.011. Epub 2016 Jan 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cerebellar Neoplasms / therapy*
  • Female
  • Humans
  • Male
  • Medulloblastoma / therapy*